Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study.

Abstract:

:The relationship between disease activity, cumulative damage and self-reported quality of life was examined in 96 patients with Systematic Lupus Erythematosus (SLE). Disease activity was measured by the SLE Disease Activity Index (SLEDAI) and cumulative damage by the Systematic Lupus International Cooperating Clinics/ACR damage index (DI). Quality of life was assessed by the Medical Outcomes Survey Short Form 20 (SF-20) self-report questionnaire which consists of six subscales. The study population was predominantly Caucasian (91%) and female (90%). The mean (+/- s.d.) age was 42.0 +/- 11.0 years and disease duration was 7.5 +/- 5.5 years. SLEDAI scores varied from 0-28, with a mean (+/- s.d.) of 4.8 +/- 5.2. The mean (+/- s.d.) DI score was 0.74 +/- 1.06, with a range of 0-5. Subscales of the SF-20 varied from 0-100 and the range of mean (+/- s.d.) scores varied from 35.0 +/- 42.2 to 70.5 +/- 28.7. There was no correlation between SLEDAI and DI scores or between SLEDAI scores and any of the six subscales of the SF-20. Likewise there was no correlation between DI scores and SF-20 subscales with the exception of Health perception (r = 0.34, P = 0.02). These results indicate that there are at least three independent dimensions of health status in SLE, namely disease activity, cumulative damage and quality of life. Furthermore, the extent of inflammatory disease activity and irreversible target organ damage are not the sole determinants for quality of life in SLE patients.

journal_name

Lupus

journal_title

Lupus

authors

Hanly JG

doi

10.1177/096120339700600305

subject

Has Abstract

pub_date

1997-01-01 00:00:00

pages

243-7

issue

3

eissn

0961-2033

issn

1477-0962

journal_volume

6

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria.

    abstract::In 1964, Miyoshi reported a series of patients with diverse symptoms after receiving treatment with silicone or paraffin fillers. Miyoshi named this condition 'human adjuvant disease'. Since then, the literature has been flooded with case reports and case series of granulomatous and systemic autoimmune disorders relat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315579092

    authors: Alijotas-Reig J

    更新日期:2015-09-01 00:00:00

  • Complementemia in pregnancies with antiphospholipid syndrome.

    abstract::Prognosis of pregnancies in women with antiphospholipid syndrome has dramatically improved over the past two decades using conventional treatment with low molecular weight heparin and low-dose aspirin. However, despite this regimen, 10-15% of antiphospholipid syndrome patients experience pregnancy losses. Several stud...

    journal_title:Lupus

    pub_type: 社论

    doi:10.1177/0961203319882507

    authors: Tabacco S,Giannini A,Garufi C,Botta A,Salvi S,Del Sordo G,Benedetti Panici P,Lanzone A,De Carolis S

    更新日期:2019-11-01 00:00:00

  • Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia.

    abstract::SLE is an autoimmune and polygenic disorder characterized by an accumulation and deposition of immune complexes. Several studies have indicated differential impact of FcgammaR polymorphism genotypes in different ethnic groups studied. The Fc receptor for IgG class IIA gene (FcgammaRIIA) occurs in two allelic forms. Th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847876

    authors: Yap SN,Phipps ME,Manivasagar M,Tan SY,Bosco JJ

    更新日期:1999-01-01 00:00:00

  • Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

    abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312444172

    authors: De Carolis S,Botta A,Santucci S,Salvi S,Moresi S,Di Pasquo E,Del Sordo G,Martino C

    更新日期:2012-06-01 00:00:00

  • Feto-maternal immune interaction at the placental level.

    abstract::A special interaction is established during pregnancy between the maternal immune system and fetal cells to allow the survival and the normal growth of the fetus. Fetal cells expressing paternal alloantigens are not recognized as foreign by the mother because of an efficient anatomic barrier and a local immunosuppress...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203304lu2010oa

    authors: Bulla R,Fischetti F,Bossi F,Tedesco F

    更新日期:2004-01-01 00:00:00

  • Environmental exposures, epigenetic changes and the risk of lupus.

    abstract::A dose-dependent combination of environmental exposures, estrogenic hormones and genetic predisposition is thought to be required for lupus to develop and flare, but how the environment modifies the immune system in genetically predisposed people is unclear. Current evidence indicates that environmental agents that in...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313499419

    authors: Somers EC,Richardson BC

    更新日期:2014-05-01 00:00:00

  • Anti-α-enolase antibody combined with β2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients.

    abstract:OBJECTIVE:Anti-α-enolase antibody (Ab) combined with β2 microglobulin (β2-MG) were investigated to predict the incidence of nephritis in systemic lupus erythematosus (SLE) patients. METHODS:Levels of serum anti-α-enolase Ab and urinary β2-MG were detected in 115 SLE patients, 29 SLE patients with nephritis and 70 heal...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319828822

    authors: Huang Y,Chen L,Chen K,Huang F,Feng Y,Xu Z,Wang W

    更新日期:2019-03-01 00:00:00

  • Photoprotective habits in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can involve multiple organ systems. Exposure to ultraviolet radiation (UVR) can exacerbate pre-existing SLE, and can even induce systemic manifestations. This study aimed to investigate the photoprotective habits of children with SLE and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320930098

    authors: Janthongsri T,Wisuthsarewong W,Nitiyarom R

    更新日期:2020-07-01 00:00:00

  • GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.

    abstract:BACKGROUND:There is no report about the association between GATA3 rs3824662 polymorphism and systemic lupus erythematosus (SLE). OBJECTIVE:To investigate the possible role of GATA3 rs3824662 polymorphism as a susceptibility risk factor for either adult SLE (aSLE) or pediatric SLE (pSLE) and to evaluate its role in the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318804894

    authors: Mosaad YM,Hammad A,Elghzaly AA,Tawhid ZME,Hammad EM,Showma A,Abdelsalam R,Elmoughy A,Fawzy IM,Anber N

    更新日期:2018-11-01 00:00:00

  • Autoimmune thyroid disorders in SLE in Singapore.

    abstract::One hundred and twenty-nine patients with systemic lupus erythematosus were screened for thyroid function tests. Of these, 8.9% had hyperthyroidism and 3.9% Hashimoto's thyroiditis. Euthyroid sick syndrome was present in 47.8% of patients. There was a high prevalence of antimicrosomal and antithyroglobulin antibodies ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200109

    authors: Boey ML,Fong PH,Lee JS,Ng WY,Thai AC

    更新日期:1993-02-01 00:00:00

  • Update on therapy--thalidomide in the treatment of lupus.

    abstract::Thalidomide has been shown to be an effective treatment for cutaneous forms of lupus erythematous refractory to other therapies. Thalidomide has very serious side effects, including teratogenicity and neuropathy, which limit its clinical use in lupus to such severe refractory cases. Efficacy has been confirmed in seve...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301677213822

    authors: Karim MY,Ruiz-Irastorza G,Khamashta MA,Hughes GR

    更新日期:2001-01-01 00:00:00

  • Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods study.

    abstract:OBJECTIVE:This study aimed to explore the experience and impact of fatigue in adults with primary antiphospholipid syndrome (pAPS). METHODS:This sequential, explanatory mixed-methods study enrolled adults with a six-month or more history of pAPS. Consenting participants completed the Functional Assessment of Chronic I...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320928421

    authors: Bearne LM,Bieles J,Georgopoulou S,Andrews J,Tully A,Stolarchuk-Prowting K,Williamson T,Suarez BS,Nel L,D'Cruz D,Lempp H

    更新日期:2020-07-01 00:00:00

  • Headaches in patients with systemic lupus erythematosus: a comparative study.

    abstract::The incidence and nature of headaches in 85 systemic lupus erythematosus (SLE) patients attending an outpatient clinic were studied and compared to those experienced by 61 nurses. The two groups were similar in age, sex and ethnicity. Test-retest assessment of reliability gave both groups 95% confidence limits of 0.09...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1050oa

    authors: Whitelaw DA,Hugo F,Spangenberg JJ,Rickman R

    更新日期:2004-01-01 00:00:00

  • Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.

    abstract::Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro through its blockade of the Fas-L of cytotoxic cells. We have investigated the extent of apoptosis and sFas leve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu250oa

    authors: Silvestris F,Grinello D,Tucci M,Cafforio P,Dammacco F

    更新日期:2003-01-01 00:00:00

  • Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.

    abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320911091

    authors: Juthong S,Geater AF,Dekumyoy P,Hortiwakul T,Siripaitoon B,Aiewruengsurat D,Thongbun N

    更新日期:2020-05-01 00:00:00

  • Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report.

    abstract::Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Cases complicated with DAH often have active SLE with multi-organ involvement, especially lupus nephritis. We describe a rare case of DAH as the first presenting manifestation of SLE in the absence of lupus neph...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311411353

    authors: Al Rashidi A,Alajmi M,Hegazi MO

    更新日期:2011-12-01 00:00:00

  • Affinity purified human antiphospholipid antibodies bind normal term placenta.

    abstract::Antiphospholipid antibodies (aPL) are associated with an increased incidence of fetal loss, but the pathophysiology remains unclear. One mechanism may involve the binding of aPL directly to the placenta where they may initiate placental thrombosis and infarction. We have developed an immunofluorescent technique to det...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840756

    authors: Donohoe S,Kingdom JC,Mackie IJ

    更新日期:1999-01-01 00:00:00

  • Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.

    abstract::Lupus nephritis (LN) is usually associated with widespread effacement of the podocytes' foot processes leading to proteinuria. Induction of urokinase receptor (uPAR) signaling in podocytes leads to foot process effacement and urinary protein loss via promoting podocytes' motility and kidney permeability in the glomeru...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313480398

    authors: Cheng CC,Lee YF,Lan JL,Wu MJ,Hsieh TY,Lin NN,Wang JM,Chiu YT

    更新日期:2013-05-01 00:00:00

  • The African Lupus Genetics Network (ALUGEN) registry: standardized, prospective follow-up studies in African patients with systemic lupus erythematosus.

    abstract:BACKGROUND:The prevalence and severity of systemic lupus erythematosus (SLE) differs between ethnic groups and geographical regions. Although initially reported as rare, there is growing evidence that SLE is prevalent and runs a severe course in Africa. There is a paucity of prospective studies on African SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315606984

    authors: Hodkinson B,Mapiye D,Jayne D,Kalla A,Tiffin N,Okpechi I

    更新日期:2016-03-01 00:00:00

  • Mycophenolate mofetil in lupus nephritis.

    abstract::There is an increasing body of literature suggesting the efficacy and tolerability of mycophenolate mofetil (MMF) for the treatment of lupus nephritis. The rationale for its use is based upon its successful profile as an immunosuppressive agent for prevention of allograft rejection, as well as studies in murine models...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2061oa

    authors: Ginzler EM,Aranow C

    更新日期:2005-01-01 00:00:00

  • Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.

    abstract::Up to 80% of patients with systemic lupus erythematosus (SLE) are treated with nonsteroidal anti-inflammatory drugs (NSAID) for musculoskeletal symptoms, serositis and headache. This survey reviews the literature on non-selective and selective inhibitors of cyclooxygenases, with an emphasis on the efficacy and safety ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120300678828794

    authors: Ostensen M,Villiger PM

    更新日期:2000-01-01 00:00:00

  • Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.

    abstract::The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600413

    authors: Muñoz-Rodríguez FJ,Font J,Badia JR,Miret C,Barberà JA,Cervera R,Ingelmo M

    更新日期:1997-01-01 00:00:00

  • Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a connective tissue disease where inflammatory activity affects several organ systems. An increased risk of cardiovascular disease has been identified in these patients, even after correction for traditional risk factors. The aim of the present study was to evaluate arterial stiff...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306071402

    authors: Bjarnegråd N,Bengtsson C,Brodszki J,Sturfelt G,Nived O,Länne T

    更新日期:2006-01-01 00:00:00

  • A case of lupus erythematosus profundus with multiple arc-shaped erythematous plaques on the scalp and a review of the literature.

    abstract::A 26-year-old Japanese female presented to us with a 2-year history of multiple arc-shaped erythematous lesions on her scalp and the right side of her forehead. Histopathological examination of two of the lesions showed lobular and septal panniculitis with deposits of IgG in the basement membrane zone. We diagnosed th...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311433917

    authors: Tsuzaka S,Ishiguro N,Akashi R,Kawashima M

    更新日期:2012-05-01 00:00:00

  • Kidney transplantation in lupus patients: a case-control study from a single centre.

    abstract::This study was conducted to determine kidney transplantation (KTx) outcomes for Greek patients with renal failure caused by lupus nephritis (LN) compared with matched controls, kidney recipients with other causes of end-stage renal disease (ESRD). Twenty-six patients with systemic lupus erythematosus (SLE) subjected t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089430

    authors: Lionaki S,Kapitsinou PP,Iniotaki A,Kostakis A,Moutsopoulos HM,Boletis JN

    更新日期:2008-07-01 00:00:00

  • Depression and systemic lupus erythematosus: a systematic review.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE) is a chronic, relapsing-remitting autoimmune disorder that involves multiple organ systems including the central nervous system. Among the items included in the nomenclature for neuropsychiatric SLE, mood disorders have been identified. The aim of this paper is to review the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313477227

    authors: Palagini L,Mosca M,Tani C,Gemignani A,Mauri M,Bombardieri S

    更新日期:2013-04-01 00:00:00

  • Emergence of panniculitis and haemophagocytic syndrome in a patient with chronic systemic lupus erythematosus.

    abstract::Panniculitis rarely occurs in the course of systemic lupus erythematosus (SLE). When it occurs, it is thought to be mainly lupus erythematosus panniculitis (LEP). Here we describe a 32-year old Japanese woman with chronic SLE, who simultaneously presented facial lymphocytic lobular panniculitis and pancytopenia due to...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307077560

    authors: Deji N,Sugimoto T,Fujimoto T,Aoyama M,Takeda N,Sakaguchi M,Uzu T,Kashiwagi A

    更新日期:2007-01-01 00:00:00

  • Infodemiology of systemic lupus erythematous using Google Trends.

    abstract::Objective People affected by chronic rheumatic conditions, such as systemic lupus erythematosus (SLE), frequently rely on the Internet and search engines to look for terms related to their disease and its possible causes, symptoms and treatments. 'Infodemiology' and 'infoveillance' are two recent terms created to desc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317691372

    authors: Radin M,Sciascia S

    更新日期:2017-07-01 00:00:00

  • Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.

    abstract::Proteinuria is a well-known risk factor for the progression of renal dysfunction in chronic kidney disease; however, its importance for estimating the prognosis of lupus nephritis requires verification. Korean adult patients with renal biopsy-diagnosed diffuse proliferative lupus nephritis who had undergone three or m...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315595130

    authors: Koo HS,Kim S,Chin HJ

    更新日期:2016-01-01 00:00:00

  • Infections in outpatients with systemic lupus erythematosus: a prospective study.

    abstract::The objective of this study was to assess the incidence and risk factors of infections in 200 SLE outpatients. All outpatients with active or inactive SLE without infections in the previous month were included. They were assessed every 3 months. Major infections were those requiring hospitalization and parental antibi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301678416088

    authors: Zonana-Nacach A,Camargo-Coronel A,Yañez P,Sánchez L,Jimenez-Balderas FJ,Fraga A

    更新日期:2001-01-01 00:00:00